CompanyAuto-indexed · Unverified
Dewpoint Therapeutics, Inc.
BOSTON, US SEC EDGAR
Every public capital-raising filing we've indexed for this company, over time. Compiled automatically from public sources — not verified by the company.
Filings
2
Total reported raised
$136.3M
People named
16
First indexed
2026
Funding history (2)
People named on filings
Ameet Nathwani, M.D. · DirectorAmir H. Nashat, Ph.D. · DirectorAmir H. Nashat, Sc.D. · DirectorAnthony A. Hyman, Ph.D. · DirectorElisabeth Leiderman · Executive OfficerFabio Pucci, Ph.D. · DirectorGiuseppe A. Ciaramella, Ph.D. · DirectorGuiseppe A. Ciaramella, Ph,D. · DirectorIsaac A. Klein, M.D., Ph.D. · Executive OfficerLori Escobedo · Executive OfficerMark Murcko, Ph.D. · DirectorOlivier Brandicourt, M.D. · DirectorRegina Barzilay, Ph.D. · DirectorRichard A. Young, Ph.D. · DirectorSrinivas Akkaraju, M.D., Ph.D. · DirectorSteven Neier, Ph.D. · Director